We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, N.I.H., EXTRAMURAL
RESEARCH SUPPORT, NON-U.S. GOV'T
RESEARCH SUPPORT, U.S. GOV'T, P.H.S.
Mutation analysis of INSL3 and GREAT/LGR8 genes in familial cryptorchidism.
Urology 2004 November
OBJECTIVES: Male mice deficient in insulin-like 3 hormone (Insl3) or its receptor, Great/Lgr8, exhibit cryptorchidism. Recently, sequence analysis of the human INSL3 and GREAT genes identified several allelic variants. These include polymorphisms without apparent functional consequence and a few alleles encoding products with compromised function. However, loss-of-function alleles appear to be rare in human cryptorchidism. Most patients studied to date are presumed to have had sporadic cryptorchidism. We postulated that any genotypic variants predisposing to cryptorchidism would be more prevalent among patients with familial cryptorchidism.
METHODS: We isolated genomic DNA from 13 individuals with personal and family histories of cryptorchidism and used polymerase chain reaction to amplify all exons of both INSL3 and GREAT, as well as INSL3 proximal promoter sequence, including a putative SF-1 transcription factor binding site. We directly sequenced all 20 amplicons and compared them with the wild-type alleles.
RESULTS: We detected two silent substitutions and one missense (A60T) substitution in exon 1 of INSL3 and two silent substitutions in exon 12 and one missense (I604V) substitution in exon 17 of GREAT, all previously described. We found that in vitro the I604V GREAT variant receptor responds to INSL3 stimulation similarly to the wild-type receptor.
CONCLUSIONS: We found polymorphic alleles of INSL3 and GREAT, but no deleterious mutations among individuals with familial cryptorchidism. Thus, mutations in these two genes are responsible only for a small proportion of familial cryptorchidism.
METHODS: We isolated genomic DNA from 13 individuals with personal and family histories of cryptorchidism and used polymerase chain reaction to amplify all exons of both INSL3 and GREAT, as well as INSL3 proximal promoter sequence, including a putative SF-1 transcription factor binding site. We directly sequenced all 20 amplicons and compared them with the wild-type alleles.
RESULTS: We detected two silent substitutions and one missense (A60T) substitution in exon 1 of INSL3 and two silent substitutions in exon 12 and one missense (I604V) substitution in exon 17 of GREAT, all previously described. We found that in vitro the I604V GREAT variant receptor responds to INSL3 stimulation similarly to the wild-type receptor.
CONCLUSIONS: We found polymorphic alleles of INSL3 and GREAT, but no deleterious mutations among individuals with familial cryptorchidism. Thus, mutations in these two genes are responsible only for a small proportion of familial cryptorchidism.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app